L-Ascorbic acid sodium salt - CAS:134-03-2

您当前的位置：

L-Ascorbic acid sodium salt (Synonyms:维生素C钠; Sodium L-ascorbate; Vitamin C sodium salt)

目录号 : KM19364 CAS No. : 134-03-2 纯度 : ≥98%

Data Sheet SDS 产品使用指南

L-Ascorbic acid sodium salt (Sodium L-ascorbate)，一种电子供体，是一种内源性抗氧化剂。L-Ascorbic acid sodium salt 选择性抑制 Ca_v3.2 通道 (Ca_v3.2 channels)，IC₅₀ 为 6.5 μM。L-Ascorbic acid sodium salt 还是一种胶原沉积促进剂和弹性生成抑制剂。

规格	价格	是否有货
500mg		In-stock
1g		In-stock
5g	询价	In-stock
10g	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

4"-Isovalerylspiramycin I In-stock
Higenamine-d4 hydrochloride In-stock
Adebrelimab In-stock
Tigatuzumab In-stock
Cosdosiran In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性

L-Ascorbic acid sodium salt (Sodium L-ascorbate), an electron donor, is an endogenous antioxidant agent. L-Ascorbic acid sodium salt inhibits selectively Ca_v3.2 channels with an IC₅₀ of 6.5 μM. L-Ascorbic acid sodium salt is also a collagen deposition enhancer and an elastogenesis inhibitor.

体外研究

The conditioned medium for B16F10 cells significantly inhibits cell apoptosis induced by L-Ascorbic acid sodium salt (Sodium L-ascorbate) (10 mM), and the effective ingredients in the medium show a relative molecular mass below 5,000.

体内研究

Tg rats treated with L-Ascorbic acid sodium salt (Sodium L-ascorbate) show a higher incidence of carcinoma (29.6%), compared to those without L-Ascorbic acid sodium salt (15.4%). Independent of the L-Ascorbic acid sodium salt treatment, transgenic rats exhibit various kinds of malignant tumors in various organs.
After 12 weeks of PEITC-treatment, both simple hyperplasia and papillary or nodular (PN) hyperplasia have developed in all animals, but the majority of these lesions have disappeared at week 48, irrespective of the L-Ascorbic acid sodium salt-treatment. The same lesions after 24 weeks of PEITC-treatment have progressed to dysplasia and carcinoma, in a small number of cases by week 48, but enhancement by the L-Ascorbic acid sodium salt-treatment is evident only with simple hyperplasias and PN hyperplasias in rats.

分子式

C₆H₇NaO₆

分子量

198.11

CAS号

134-03-2

中文名称

L-抗坏血酸钠；维生素C钠

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

2-8°C, sealed storage, away from moisture and light

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据

In Vitro:

H₂O : 100 mg/mL (504.77 mM; Need ultrasonic)

DMSO : 1 mg/mL (5.05 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	5.0477 mL	25.2385 mL	50.4770 mL
5 mM	1.0095 mL	5.0477 mL	10.0954 mL
10 mM	0.5048 mL	2.5239 mL	5.0477 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

临床试验

科研文献